Cargando…

Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy

Detalles Bibliográficos
Autores principales:	Reimann, Hannah, Kremer, Anita N., Blumenberg, Viktoria, Schmidt, Katja, Aigner, Michael, Jacobs, Benedikt, Eisenhauer, Nina, Kämpf, Alina, Rösler, Wolf, Kharboutli, Soraya, Mougiakakos, Dimitrios, Lang, Vanessa, Lischer, Christopher, Irrgang, Pascal, Leppkes, Moritz, Gonzalez, Julio Vera, Krönke, Gerhard, Kremer, Andreas E., Tenbusch, Matthias, Bruns, Heiko, Harrer, Thomas, Müller, Fabian, Schett, Georg, Mackensen, Andreas, Subklewe, Marion, Völkl, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554322/ https://www.ncbi.nlm.nih.gov/pubmed/36206194 http://dx.doi.org/10.1182/bloodadvances.2022007806

Ejemplares similares

Thrombopoietin receptor agonists for acquired thrombocytopenia following anti-CD19 CAR-T-cell therapy: a case report
por: Baur, Rebecca, et al.
Publicado: (2021)

Case Report: IBD-like colitis following CAR T cell therapy for diffuse large B cell lymphoma
por: Zundler, Sebastian, et al.
Publicado: (2023)

Upregulation of CCR4 in activated CD8(+) T cells indicates enhanced lung homing in patients with severe acute SARS‐CoV‐2 infection
por: Spoerl, Silvia, et al.
Publicado: (2021)

Role of CAR T Cell Metabolism for Therapeutic Efficacy
por: Rial Saborido, Judit, et al.
Publicado: (2022)

Human Double-Negative Regulatory T-Cells Induce a Metabolic and Functional Switch in Effector T-Cells by Suppressing mTOR Activity
por: Haug, Tabea, et al.
Publicado: (2019)

Human CD4(+) T cells specific for dominant epitopes of SARS‐CoV‐2 Spike and Nucleocapsid proteins with therapeutic potential
por: Verhagen, Johan, et al.
Publicado: (2021)

Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells
por: Bergmann, Christina, et al.
Publicado: (2023)

The Oncometabolite 5′-Deoxy-5′-Methylthioadenosine Blocks Multiple Signaling Pathways of NK Cell Activation
por: Jacobs, Benedikt, et al.
Publicado: (2020)

Bone marrow stroma cells promote induction of a chemoresistant and prognostic unfavorable S100A8/A9(high) AML cell subset
por: Böttcher, Martin, et al.
Publicado: (2022)

CLL-Derived Extracellular Vesicles Impair T-Cell Activation and Foster T-Cell Exhaustion via Multiple Immunological Checkpoints
por: Böttcher, Martin, et al.
Publicado: (2022)

IL-21 modulates memory and exhaustion phenotype of T-cells in a fatty acid oxidation-dependent manner
por: Loschinski, Romy, et al.
Publicado: (2018)

The metabolic profile of reconstituting T-cells, NK-cells, and monocytes following autologous stem cell transplantation and its impact on outcome
por: Richter, Silja, et al.
Publicado: (2022)

CD137 (4-1BB) stimulation leads to metabolic and functional reprogramming of human monocytes/macrophages enhancing their tumoricidal activity
por: Stoll, A., et al.
Publicado: (2021)

Successful treatment of COVID‐19 infection with convalescent plasma in B‐cell‐depleted patients may promote cellular immunity
por: Kremer, Andreas E., et al.
Publicado: (2021)

Cytokine and reactivity profiles in SLE patients following anti-CD19 CART therapy
por: Nunez, Daniel, et al.
Publicado: (2023)

Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use
por: Bücklein, Veit, et al.
Publicado: (2023)

The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL
por: Rejeski, Kai, et al.
Publicado: (2022)

Reconstitution of EBV-directed T cell immunity by adoptive transfer of peptide-stimulated T cells in a patient after allogeneic stem cell transplantation for AITL
por: Lammoglia Cobo, María Fernanda, et al.
Publicado: (2022)

Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections
por: Huber, Timo, et al.
Publicado: (2021)

Correction to: Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections
por: Huber, Timo, et al.
Publicado: (2021)

Linking Immunoevasion and Metabolic Reprogramming in B-Cell–Derived Lymphomas
por: Böttcher, Martin, et al.
Publicado: (2020)

Accumulation of T-cell-suppressive PD-L1(high) extracellular vesicles is associated with GvHD and might impact GvL efficacy
por: Baur, Rebecca, et al.
Publicado: (2023)

Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL
por: Blumenberg, Viktoria, et al.
Publicado: (2023)

CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells
por: Jitschin, Regina, et al.
Publicado: (2018)

Control of PD-L1 expression in CLL-cells by stromal triggering of the Notch-c-Myc-EZH2 oncogenic signaling axis
por: Böttcher, Martin, et al.
Publicado: (2021)

T-Cell Metabolism in Graft Versus Host Disease
por: Karl, Franziska, et al.
Publicado: (2021)

Vascular occlusion by neutrophil extracellular traps in COVID-19
por: Leppkes, Moritz, et al.
Publicado: (2020)

Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty(®))
por: Held, Jürgen, et al.
Publicado: (2021)

SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases
por: Simon, David, et al.
Publicado: (2021)

Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion
por: Simon, David, et al.
Publicado: (2020)

Humoral and Cellular Immune Responses to SARS–CoV‐2 Infection and Vaccination in Autoimmune Disease Patients With B Cell Depletion
por: Simon, David, et al.
Publicado: (2021)

Retrograde inspection vs standard forward view for the detection of colorectal adenomas during colonoscopy: A back-to-back randomized clinical trial
por: Rath, Timo, et al.
Publicado: (2020)

Combination of lenalidomide and vitamin D enhances MOR202-mediated cytotoxicity of macrophages: It takes three to tango
por: Flamann, Cindy, et al.
Publicado: (2019)

Breaking barriers: NEK2 inhibition shines in multiple myeloma treatment
por: Lischer, Christopher, et al.
Publicado: (2023)

Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS–CoV‐2 in an Unvaccinated Cohort
por: Simon, David, et al.
Publicado: (2022)

P1447: INFERIOR OUTCOMES OF EU VS. US PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA AFTER CD19 CAR T-CELL THERAPY ARE IMPACTED BY BASELINE RISK FACTORS AND CAR PRODUCT CHOICE
por: Bücklein, V., et al.
Publicado: (2022)

Identifying Early Infections in the Setting of CRS With Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHL
por: Rejeski, Kai, et al.
Publicado: (2023)

IgA2 Antibodies against SARS-CoV-2 Correlate with NET Formation and Fatal Outcome in Severely Diseased COVID-19 Patients
por: Staats, Léonie A. N., et al.
Publicado: (2020)

Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2
por: Lapuente, Dennis, et al.
Publicado: (2020)

Hydrogen-Peroxide Synthesis and LDL-Uptake Controls Immunosuppressive Properties in Monocyte-Derived Dendritic Cells
por: Menzner, Ann-Katrin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v3s39sfpoa5o11i1mnvh3s0uu8